A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy

Annals of Neurology
M DalakasC Otero

Abstract

Eleven patients with demyelinating polyneuropathy associated with monoclonal IgM antibodies were randomized to receive IVIg or placebo, monthly, for 3 months in a double-blind study. After a washout period, they crossed over to the alternate therapy. Response was gauged by evaluating muscle strength, sensation, and neuromuscular symptoms at baseline, after 3 months, and at treatment's end. After IVIg therapy, the strength improved in only 2 of 11 patients, by 28 and 38.5 points from baseline, and declined after placebo. In 1 other patient, the sensory score improved by 13 points. Antibody titers to MAG/SGPG or gangliosides did not appreciably change. We conclude that IVIg has only a modest benefit to not more than 18% of patients with IgM paraproteinemic demyelinating neuropathy.

References

Jan 1, 1979·British Journal of Clinical Pharmacology·D D Breimer
Jul 1, 1979·British Journal of Clinical Pharmacology·M Hills, P Armitage
Mar 8, 1990·The New England Journal of Medicine·S MonacoL Bonazzi
Jan 1, 1989·Methods in Enzymology·R H Quarles
Jun 1, 1986·Annals of Neurology·M C Dalakas
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·A A IlyasR O Brady
Jul 1, 1981·Annals of Neurology·M C Dalakas, W K Engel
Mar 1, 1983·Brain : a Journal of Neurology·I S SmithP K Thomas
Nov 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·J M LegerP Brunet
Dec 30, 1993·The New England Journal of Medicine·M C DalakasS McCrosky

❮ Previous
Next ❯

Citations

Apr 15, 2000·Journal of Clinical Apheresis·R Weinstein
Apr 19, 2005·Journal of Neurology·Eduardo Nobile-Orazio
Sep 26, 2006·Journal of Neurology·Ralf Gold, Bernd C Kieseier
Sep 20, 2008·Journal of Neurology·Richard Hughes
Jan 16, 2007·Current Neurology and Neuroscience Reports·Thomas B Toothaker, Thomas H Brannagan
Nov 18, 2011·Current Neurology and Neuroscience Reports·Sindhu Ramchandren, Richard A Lewis
Sep 16, 2010·Current Treatment Options in Neurology·Marinos C Dalakas
Jul 11, 2009·Clinical Reviews in Allergy & Immunology·Shaye KivityYehuda Shoenfeld
Mar 25, 1998·Journal of the Neurological Sciences·M StangelR Gold
Jan 6, 2000·Transfusion Science·J M Léger
Jan 6, 2007·Nature Clinical Practice. Neurology·Ralf GoldMarinos C Dalakas
Mar 6, 2003·Reviews in Clinical and Experimental Hematology·Robert A Kyle, S Vincent Rajkumar
May 29, 1998·The New England Journal of Medicine·A H Ropper, K C Gorson
Aug 2, 2006·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Carol Lee Koski, Jardiolyn Valino Patterson
Mar 1, 2006·Journal of Clinical Neuromuscular Disease·Norman LatovJean Michel Vallat
Aug 2, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·UNKNOWN European Federation of Neurological SocietiesI N van Schaik
Sep 18, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I ElovaaraUNKNOWN EFNS
Mar 23, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Y A Rajabally
Jul 21, 1998·Annals of the New York Academy of Sciences·P Fredman
Apr 21, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·H C WilsonR A Hughes
Apr 8, 1998·Annual Review of Neuroscience·T W HoJ W Griffin
Jun 29, 2011·Rinshō shinkeigaku = Clinical neurology·Takashi ShimoyamaSoichiro Mochio
Jan 30, 2016·BMC Neurology·Richard A Rison, Said R Beydoun
Sep 25, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jan D LünemannMarinos C Dalakas
Apr 27, 2013·La Presse médicale·Ricard Rojas-GarcíaIsabel Illa
May 7, 2013·La Presse médicale·Marinos C Dalakas
May 25, 2007·Journal of the Neurological Sciences·Wayne W L Lai, Eroboghene E Ubogu
Apr 3, 2007·Transfusion Medicine Reviews·Tom FeasbyLouis Wadsworth
Feb 28, 2007·Neurologic Clinics·Justin Y Kwan
Jul 8, 2008·Journal of the Peripheral Nervous System : JPNS·Sonja I van NesIngemar S J Merkies
May 11, 2012·Journal of the Peripheral Nervous System : JPNS·Marinos C Dalakas
Mar 24, 2016·Biomolecules·Ana Filipa Barahona Afonso, Cristina Maria Pires João

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.